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Melbourne, Victoria, AustraliaA B S T R A C TBackground: Valid and relevant estimates of health state preference
weights (HSPWs) for Glasgow Outcome Scale (GOS) categories are a
key input of economic models evaluating treatments for traumatic
brain injury (TBI). Objectives: To characterize existing HSPW esti-
mates, and model the EuroQol ﬁve-dimensional questionnaire (EQ-5D)
from the GOS, to inform parameterization of future economic models.
Methods: A systematic review of HSPWs for GOS categories following
TBI was conducted using a highly sensitive search strategy imple-
mented in an extensive range of information sources between 1975
and 2016. A cross-sectional mapping study of GOS health states onto
the three-level EQ-5D UK tariff index values was also performed in
patients with signiﬁcant TBI (head region Abbreviated Injury Scale
score Z3) from the Victoria State Trauma Registry. A limited depend-
ent variable mixture model was used to estimate the 12-month EQ-5D
UK value set as a function of GOS category, age, and other explanatory
variables. Results: Six unique HSPWs from ﬁve eligible studies
were identiﬁed. All studies were at high risk of bias with limited
applicability. The magnitude of HSPWs differed signiﬁcantly betweenee front matter Copyright & 2016, International S
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shefﬁeld.ac.uk.
ndence to: Gordon Ward Fuller, Emergency Medicin
d Research (ScHARR), University of Shefﬁeld, Regestudies. Three class mixture models demonstrated excellent goodness
of ﬁt to the observed Victoria State Trauma Registry data. GOS
category, age at injury, sex, comorbidity, and major extracranial injury
all had signiﬁcant independent effects on mean EQ-5D utility values.
Conclusions: The few available HSPWs for GOS categories are
challenged by potential biases and restricted generalizability.
Mixture models are presented to provide HSPWs for GOS categories
consistent with the National Institute for Health and Care Excellence
reference case.
Keywords: craniocerebral trauma, decision analysis models, economic
models, EuroQol-5D, Glasgow Outcome Scale, health status indicators,
mapping study, quality-adjusted life-years, quality of life, systematic
review.
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Increasing health care demands, limited by ﬁnite health budgets,
have necessitated economic evaluations of new health technol-
ogies to ensure efﬁcient use of scarce resources [1]. Cost-
effectiveness is commonly assessed by comparing interventions
in terms of costs and quality-adjusted life-years, comprising
duration of life expectancy weighted by preferences for health-
related quality of life (HRQOL) over this period [2].
Incremental costs per quality-adjusted life-year in economic
evaluations are often derived using decision analysis modeling to
synthesize available evidence and represent hypothetical
patients’ responses to alternative interventions [3]. Valid and
relevant estimates of preference weights for deﬁned outcome
states (health state preference weights [HSPWs]) are a key inputof such models [4]. Systematic literature searching is the meth-
odological standard to ensure transparent and complete identi-
ﬁcation of HSPW estimates [5]. In the absence of valid empirical
values for HSPWs, “mapping” of non–preference-based measures
of health to generic-based measures can be performed [5], with
the UK National Institute for Health and Care Excellence (NICE)
recommending that HRQOL be measured directly from patients
using the EuroQol ﬁve-dimensional questionnaire (EQ-5D) and
valued by a UK tariff of general population preferences [6].
Background information on the EQ-5D is provided in the Web
Appendix in Supplemental Materials found at http://dx.doi.org/
10.1016/j.jval.2016.09.2398.
Traumatic brain injury (TBI) is a major public health problem
in the United Kingdom, being one of the leading causes of death
and disability and costing the economy an estimated £4 billionociety for Pharmacoeconomics and Outcomes Research (ISPOR).
BY license (http://creativecommons.org/licenses/by/4.0/).
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Table 1 – Review inclusion and exclusion criteria.
Inclusion criteria
 Disease: Mild, moderate, or severe TBI*
 Disease population: Adult patients with TBI 4 16 y
 Health states: Consistent with GOS categories
 Population describing health states: Patients, carers, or health
professionals
 Method for measuring HRQOL for each health state: Scenarios,
generic multiattribute utility instruments, disease-speciﬁc
multiattribute health instruments, direct measurement
 Method for determining preferences for HRQOL for each health
state: Direct preference-based valuation of GOS health states
V A L U E I N H E A L T H ] ( 2 0 1 6 ) ] ] ] – ] ] ]2per year [7,8]. Outcome in TBI effectiveness studies is conven-
tionally assessed using the basic or extended Glasgow Outcome
Scale (GOS), measuring death and severity of disability using an
ordinal scale [9]. Health state valuations corresponding to these
outcomes are therefore necessary for health economic models
examining new health technologies in TBI, but despite their
importance there is a paucity of suitable estimates.
The aim of this study was to provide a comprehensive
reference source of HSPWs for GOS health states following adult
TBI to inform parameterization of future economic models.
Speciﬁc objectives were to systematically identify all HSPWs
available at present for GOS states following TBI and to validly
derive estimates of HSPWs for GOS from the EQ-5D.using recognized elicitation method (SG, VAS, or TTO); indirect
valuation of GOS health states (following health state
measurement with generic or disease-speciﬁc multiattribute
utility instruments) using recognized elicitation method (SG, VAS,
or TTO).
 Population providing preferences for HRQOL of health states:
General public, patients, carers, health professionals
 Study types: Original HSPV research study reporting at least one
unique HSPV
 Language: English language or available translation
 Dates: 1975 to present
Exclusion criteria
 Disease: Non-TBI conditions (e.g., stroke)
 Disease population: Pediatric patients, aged o 16 y
 Health state measurement: Methods not suitable for mapping to
the EQ-5D
 Health state valuation method: Non–preference-based valuation
of health states (e.g., expert opinion used to value health states)
AIS, Abbreviated Injury Scale; EQ-5D, EuroQol ﬁve-dimensional
questionnaire; GCS, Glasgow Coma Scale; GOS, Glasgow Outcome
Scale; HRQOL, health-related quality of life; HSPW, Health State
Preference Weights; SG, standard gamble; TBI, traumatic brain
injury. TTO, time trade-off; VAS, visual analogue scale.
* TBI severity categorized according to GCS score or head region
AIS score: mild TBI: GCS 14–15 or AIS 1 or 2; moderate TBI: GCS
9–13 or AIS 3; severe TBI: GCS r 8 or AIS 4–6.Methods
A systematic review and a cross-sectional study mapping GOS
health states onto the three-level EQ-5D (EQ-5D-3L) UK tariff
index values were conducted.
Systematic Review
Study design and criteria for considering studies
A detailed review protocol stating an a priori analysis plan was
developed before data collection. The review inclusion and
exclusion criteria are presented in Table 1. All methods of
obtaining HSPWs were eligible, with the exception of elicitation
using expert opinion, which is limited by high risk of bias and
lack of descriptive validity [5].
Identiﬁcation of evidence
An extensive range of electronic information sources were
examined including all major bibliographic databases, specialist
health economic and gray literature databases, and relevant Web
sites. Additional information sources included forward and back-
ward citation searching, author searching, reference checking,
and contact with experts. Search strategies for bibliographic
databases were developed iteratively in conjunction with an
information services specialist and underwent external peer
review. Searches were conducted for original research published
between 1975 (corresponding to the introduction of the GOS) and
week 33, April 2015. Present awareness searches were conducted
in MEDLINE and Embase (week 3, April 2016) immediately before
submission. Full details on information sources and search
strategies are presented in the Web Appendix in Supplemental
Materials.
Selection of evidence and data extraction
All studies identiﬁed during searches were assessed in a three-
stage process with an initial screening of titles for relevance,
followed by further examination of abstracts and full-text articles
as required to assess eligibility. Studies were then classiﬁed as
follows: eligible if inclusion criteria were met; potentially eligible
if information was collected that could potentially allow calcu-
lation of HSPWs but estimates were not reported (e.g., short form
36 health survey and GOS both measured simultaneously); or
ineligible. Relevant information on study characteristics and
methodology was then collected for eligible and potentially
eligible studies using a prespeciﬁed data extraction form. Study
selection and data extraction were performed by a single
reviewer and checked by a second independent reviewer.
Appraisal of quality, data synthesis, and statistical analyses
Included HSPW studies were assessed for quality using a peer-
reviewed critical appraisal checklist based on the NICE DecisionSupport Unit guidelines [5], the Cochrane risk of bias tool [10], and
theoretical considerations (further details are provided in the
Web Appendix in Supplemental Materials) [11,12]. The risk of bias
in each domain was subsequently rated as high, low, or unclear.
A narrative synthesis of identiﬁed HSPWs was prespeciﬁed in the
event that clinically and methodologically homogeneous studies
at low risk of bias were not identiﬁed. To facilitate comparisons,
reported measures of variance for HSPWs were converted to 95%
conﬁdence intervals (CIs). Extended GOS category HSPWs were
combined using weighted averages to provide results for com-
mensurate basic GOS health states. One-way analyses of variance
(ANOVAs) using published summary statistics were used to test
for statistically signiﬁcant differences between HSPW estimates
within each basic GOS category. Post hoc Scheffe multiple-
comparison hypothesis tests for differences in means were then
used to identify which HSPW estimates differed [13].
Mapping Study
Study design
A retrospective cohort study was performed by analyzing data
from the Victorian State Trauma Registry (VSTR) [14]. A model for
predicting mean EQ-5D HSPWs for GOS categories at 12 months
postinjury was developed using adjusted limited dependent
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shown to outperform other models when properly speciﬁed
[15–19], and follows the draft of the International Society for
Pharmacoeconomics and Outcomes Research Good Practices on
mapping of utilities [20].
Setting and study population
The VSTR is a population-based database that has collected informa-
tion on all major trauma cases within the state of Victoria, Australia,
since 2001 [14]. Patients are included if they meet any of the following
criteria: Injury Severity Score of more than 12; admission to critical
care for more than 24 hours, with mechanical ventilation for at least
part of that time, as a result of injury; urgent surgery secondary to
major trauma; or death due to injury. Consecutive cases are pro-
spectively identiﬁed from emergency admission data, discharge data,
review of hospital case notes, and coroners’ records by VSTR data
collectors in each hospital. The study population comprised consec-
utive adults (Z16 years) enrolled in VSTR with signiﬁcant TBI (head
region Abbreviated Injury Scale severity score Z3) and injured
between January 2008 and June 2013 [21,22]. Deceased patients in
the GOS 1 category by deﬁnition had an HSPW value of 0 and were
excluded from consideration in predictive models.
Data collection
The VSTR contains an extensive data set of demographic,
physiological, injury, investigation, and treatment and outcome
variables. Data are collected from prehospital and inpatient case
notes, hospital information systems, and the National Coroner’s
Information System and submitted by electronic upload or Web-
based entry systems. Linkage between separate hospital admis-
sions in the case of interhospital transfer is achieved determin-
istically on the basis of demographic identiﬁers. Postdischarge
follow-up is conducted by telephone interviews at 6, 12, and 24
months and includes standardized questionnaires for the
extended GOS and the EQ-5D-3L. To meet the NICE reference
case for economic evaluations, the EQ-5D-3L was then valued
using the UK tariff [6,23].
Statistical analyses
The injury and demographic features of the study cohort were
characterized using descriptive statistics. Adjusted limited depend-
ent variable mixture models were then developed to predict mean
EQ-5D preference weights for each basic GOS health state at 12
months, conditional on important patient characteristics [17,19,24].
An initial simple model was developed with 12-month EQ-5D as
the dependent variable and GOS category and age as explanatory
variables. An additional detailed model was developed, with age,
sex, comorbidities, and the presence of extracranial injury eval-
uated as further covariates likely to be important characteristics of
TBI populations modeled in economic evaluations. The goodness
of model ﬁt was evaluated using information criterion statistics,
mean absolute error, root mean squared error, and visual compar-
ison of predicted and observed values. Models were validated by
out-of-sample predictions for EQ-5D at 6 and 24 months postinjury
within the same cohort, and comparing cumulative distribution
functions. Secondary analyses examining the extended GOS and a
range of international EQ-5D tariff values were also performed.
Further details on adjusted limited dependent variable mixture
models, the modeling strategy, and secondary analyses are given
in the Web Appendix in Supplemental Materials.
Ethics, funding, and statistical software
The VSTR has the approval of the Human Research Ethics
Committee to collect data from all participating health services.
Speciﬁc ethical approval for the present study was obtained fromthe Monash University Human Research Ethics Committee, and
the Steering Committee of the VSTR approved the provision of
de-identiﬁed data for this study. A two-sided P value of less than
0.05 was considered to be statistically signiﬁcant. All statistical
analyses were carried out in Stata version 12.1 (StataCorp, College
Station, TX). The Stata aldvmm module was used to perform
adjusted limited dependent variable mixture modeling [24].Results
Systematic Review
Study selection
In this study, 13,500 citations were screened for eligibility, with
the full text of 341 articles retrieved for detailed evaluation.
During full-text examination, ﬁve studies were found that
described six sets of HSPWs for GOS or comparable health states
following TBI [18–21]. Forty-one potentially eligible “near-miss”
studies were collected on GOS and a preference-based health
state description scale (or a non–preference-based HRQOL instru-
ment with established mapping function) but were ultimately not
included because HSPW estimates were not reported. Figure 1
shows the selection of studies in detail.
HSPW study characteristics
Two studies used case scenarios to describe health states corre-
sponding to GOS categories ([40] [extended GOS]; Aoki, 1995
[GOS]). Preferences for HRQOL were then directly determined by
external populations using the standard gamble technique [12]. A
third study (Djikers, 2004) also used case vignettes, broadly
comparable to GOS states, to formulate HSPWs. Quality of Well-
Being and Health Utility Index 3 generic multiattribute health
description instruments were then applied by the author, allow-
ing indirect determination of preferences using the appropriate
preference valuation algorithm [12]. [42] measured GOS and
HRQOL using the Rosser Index of Health-Related Quality of Life
[12], asking patients to recall their health status in the years
following their head trauma. Preferences were then determined
indirectly for GOS categories using the Rosser valuation matrix,
and a smoothing regression function was applied to estimate
mean utility for each year from 1 to 7 postinjury. Finally, [43]
measured both the GOS and the EQ-5D in a sample of patients
with complicated mild head injury. Preferences were then deter-
mined indirectly for the GOS categories from the Dutch EQ-5D
tariff [12]. The characteristics of included HSPW studies are
presented in further detail in the Web Appendix in Supplemental
Materials.
Reported results and risk of bias
HSPW estimates for each GOS state are presented in Table 2.
Signiﬁcant variations in HSPWs were evident, with those
reported by [42] being appreciably higher across all GOS catego-
ries (ANOVA Po 0.001). Despite the relatively small sample sizes,
these differences reached statistical signiﬁcance for categories of
moderate and severe disability (ANOVA and Scheffe multiple-
comparison test P o 0.001). Differences were in excess of
previously reported minimum clinically important differences
for the EQ-5D (mean 0.074 [range 0.011 to 0.140]) [25].
Risk of bias was high for each study using health state
scenarios ([40]; Djikers, 2004; Aoki, 1995) secondary to unvalidated
GOS descriptions and nonrepresentative valuing populations.
Risk of bias was also high for studies measuring health states
directly from patients. Additional information available from [43]
indicated substantial loss to follow-up (43%). [42] also reported
marked loss to follow-up (72%), and was further limited by the
Fig. 1 – PRISMA ﬂowchart describing systematic review study selection. De-duplication was performed at the full-text stage
and a one-to-one relationship subsequently existed between articles and studies. *Six unique GOS HSPWs reported in ﬁve
articles. GOS, Glasgow Outcome Scale; HSPWs, health state preference weights; PRISMA, Preferred Reporting Items for
Systematic Reviews and Meta-Analyses.
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several years previously, with the consequent potential for recall
bias. The risk of bias for each HSPW estimate is presented in
Table 3, with a detailed rationale presented in the Web Appendix
in Supplemental Materials.Mapping of GOS Categories onto UK Tariff EQ-5D Index
Values
Sample characteristics
A study sample of 3437 VSTR patients meeting inclusion criteria
and with complete information on 12-month EQ-5D and 12-month
GOS was included in a complete case analysis. The median age of
the study sample was 50 years (interquartile range 29–72), with
males accounting for 71.3% of cases (95% CI 69.8–72.9%). The
median Injury Severity Score was 21 (interquartile range 16–26).
The distributions of 12-month EQ-5D values, overall and after
stratiﬁcation by GOS category, are presented in frequency histo-
grams in Figure 2. Typical features of the EQ-5D distribution
including multimodality, local maxima with variable skewness
and kurtosis, discontinuity, and distinct probability masses were
evident [12]. Further details on derivation of the study sample and
patient characteristics are provided in the Web Appendix in
Supplemental Materials. Brieﬂy, there was a moderate proportion
of missing data for important study variables, ranging from 0% for
age and sex to 27% for 12-month EQ-5D. Patients excluded from
the available case analyses because of missing data had character-
istics similar to those of included patients.Predictive modeling of EQ-5D preference weights on the basis of
GOS category
The preferred model predicting EQ-5D index scores from GOS
category and age, chosen on the basis of parsimony and
relative favorability of goodness-of-ﬁt statistics (Table 4),
included three latent classes. Model coefﬁcients are presented
in Table 5. The addition of a fourth latent class provided a
negligible improvement in model ﬁt at the expense of
increased model complexity. Age and GOS category demon-
strated a signiﬁcant effect on the probability of latent class
membership and the distribution of mean EQ-5D scores within
each component. As shown in Figure 3, model predictions
showed excellent concordance with observed values, demon-
strating relatively lower HSPWs for vegetative state and severe
disability GOS categories in younger patients than in older
patients, with the opposite relationship apparent for favorable
GOS categories of moderate disability and good recovery. Out-
of-sample prediction of EQ-5D at 24 months postinjury also
showed excellent agreement between observed and predicted
values as shown by the cumulative distribution functions in
Figure 4. There was, however, an underprediction of the EQ-5D
at 6 months for those patients with little or no functional
disability (Fig. 4).
The most favorable detailed model, including the additional
covariates of age, sex, comorbidity, and extracranial injury, also
used three latent classes (Table 5). Each covariate had a signiﬁ-
cant association with the probability of latent class membership,
or the EQ-5D distribution within each component. A similar
Table 2 – HSPW estimates for basic and extended GOS categories.
GOS category Utility estimates: mean (95% CI) ANOVA for
basic
GOS
states¶
[41]* [42]†,‡ Djikers
(2004)†,§: QWB
Djikers
(2004)†,§: HUI3
[43]* [40]: GOS|| [40]: GOSE
(n ¼ 140) (n ¼ 99) (n ¼ 1) (n ¼ 1) (n ¼ 87) (n ¼ 101) (n ¼ 101)
1: Death 0.0 (0.0) 0.0 0.0 0.0 0.0 (0.0–0.0) 0.0 (0.0) 0.0 (0.0) –
2: Persistent vegetative
state*
0.08 (0.05–0.11) – – – – 0.11 (0.07–0.15) 0.11 (0.07–0.15) P ¼ 0.24
3: Severe disability 0.26 (0.22–0.30) 0.71 0.43 0.13 0.15 (0.06–0.28) 0.50 (0.46–0.53) – P o 0.001
0.41 (0.37–0.45)[GOSE 3: Lower severe
disability]
0.58 (0.54–0.62)[GOSE 4: Upper severe
disability]
4: Moderate disability 0.63 (0.58–0.68) 0.94 0.53 0.48 0.51 (0.39–0.63) 0.76 (0.73–0.78) – P o 0.001
0.47 0.33 0.70 (0.67–0.73)
0.60 0.63 0.81 (0.78–0.84)
[GOSE 5: Lower
moderate disability]
[GOSE 6: Upper
moderate disability]
5: Good recovery 0.85 (0.82–0.88) 0.94 0.80 0.93 0.88 (0.71–0.97) 0.93 (0.91–0.95) – P ¼ 0.24
0.86 (0.83–0.89)[GOSE 5: Lower good
recovery]
1.00 (1.00–1.00)[GOSE 6: Upper good
recovery]
ANOVA, analysis of variance; CI, conﬁdence interval; GOS, Glasgow Outcome Scale; GOSE, extended GOS; HSPW, health state preference weight; HUI, Health Utility Index; NA, not applicable;
QWB, Quality of Well-Being.
* Persistent vegetative state not observed in [42]/[43] and not assessed for [44].
† Variance not reported in [42] and not applicable for [44].
‡ [42] reported multiple HSPW estimates across several years of follow-up for each GOS category. The category-speciﬁc mean HSPW is reported herein.
§ Indirect determination of preferences for health states measured from scenarios using generic multiattribute preference-based health description instrument.
|| Basic GOS categories calculated from published GOSE scores using weighted averages.
¶ ANOVA for basic GOS categories only.
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Table 3 – Critical appraisal of HSPW estimates: Risk of bias in each domain rated high, low, or unclear.
Study Health state description and
measurement
Health state valuation Other sources
of bias
Overall
Selection bias Information bias Selection bias Information bias
[40] NA Low High Low Low High
[43] High Low Low Low Low High
Djikers (2004) NA High High Low Low High
[42] High High Unclear Unclear Low High
[41] NA High Unclear Low Low High
HSPW, health state preference weight; NA, not applicable.
F
q
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sample prediction at 24 months postinjury was evident but
underprediction of high EQ-5Ds at 6 months postinjury was again
observed (Fig. 3). Further details on the results of the detailed
model for GOS, including variable coefﬁcients, are provided in the
Web Appendix in Supplemental Materials.
Results of secondary analyses examining international tariff
EQ-5D estimates for GOS categories, and adjusted limited
dependent variable mixture models including extended GOS
categories, are presented in the Web Appendix in Supplemen-ig. 2 – Distribution of EQ-5D at 12 months overall, and stratiﬁed
uestionnaire; GOS, Glasgow Outcome Scale.tal Materials. Brieﬂy, the EQ-5D estimates varied signiﬁcantly
between countries both statistically (Friedman test P o 0.001)
and clinically (differences in excess of minimum clinically
important differences). Preferred models predicting EQ-5D
index scores from extended GOS category included four latent
classes, with each covariate having a statistically signiﬁcant
association with the EQ-5D distribution within each compo-
nent. A Stata “do ﬁle” providing mean predicted EQ-5D and 95%
CIs, conditional on GOS category and covariates, is provided as
an additional supplementary ﬁle.by basic GOS category. EQ-5D, EuroQol ﬁve-dimensional
Table 4 – Goodness-of-ﬁt metrics for simple and detailed models predicting EQ-5D from basic GOS category.
Number of latent classes AIC BIC Mean error MAE RMSE
Simple model: Basic GOS and age
1 2173.715 2210.569 0.006147 0.196555 0.25746045
2 1023.686 1128.106 0.00076 0.193722 0.25608219
3 960.9117 1120.613 0.000605 0.193344 0.25592006
4 955.7214 1170.704 0.000645 0.193304 0.25589877
Number of latent classes AIC BIC Mean error Absolute error RMSE
Detailed model: Basic GOS and age, sex, comorbidity, extracranial injury
1 869.4129 1026.339 0.00067 0.194383 0.25614
2 820.5065 1031.753 0.00077 0.192999 0.254911
3 806.3804 1029.698 0.00076 0.192481 0.25466
4 810.1862 1045.575 0.00079 0.192521 0.254685
Note. Most favorable result for each metric of goodness of ﬁt highlighted in bold text.
AIC, Akaike information criterion; BIC, Bayesian information criterion; EQ-5D, EuroQol ﬁve-dimensional questionnaire; GOS, Glasgow Outcome
Scale; MAE, mean absolute error; RMSE, root mean squared error.
Table 5 – Coefﬁcients for the initial adjusted limited dependent variable mixture model predicting 12-mo EQ-5D
HSPWs from basic GOS category and age.
Variable* Coefﬁcient SE P value 95% CI
Explanatory variables within component 1
Vegetative state 0.524 0.077 0.000 0.675 to 0.373
Severe disability 0.196 0.049 0.000 0.293 to 0.099
Moderate disability 0.053 0.051 0.296 0.154 to 0.047
Age 0.001 0.005 0.815 0.008 to 0.010
Constant 0.280 0.053 0.000 0.176 to 0.385
Explanatory variables within component 2
Vegetative state 0.778 0.114 0.000 1.002 to 0.554
Severe disability 0.001 0.092 0.991 0.182 to 0.180
Moderate disability 0.041 0.077 0.598 0.111 to 0.192
Age 0.011 0.002 0.000 0.015 to 0.008
Constant 0.844 0.054 0.000 0.737 to 0.950
Explanatory variables within component 3
Vegetative state† – – – – –
Severe disability 0.337 0.047 0.000 0.429 to 0.245
Moderate disability 0.282 0.036 0.000 0.353 to 0.211
Age 0.012 0.002 0.000 0.015 to 0.009
Constant 1.002 0.020 0.000 0.962 to 1.042
Explanatory variables explaining the probability of component 1 membership
Vegetative state 20.562 1.441 0.000 17.738 to 23.386
Severe disability 3.962 0.298 0.000 3.378 to 4.546
Moderate disability 2.785 0.333 0.000 2.133 to 3.437
Age 0.002 0.039 0.957 0.075 to 0.079
Constant 3.143 0.273 0.000 3.679 to 2.607
Explanatory variables explaining the probability of component 2 membership
Vegetative state 17.000 – – – –
Severe disability 0.697 0.244 0.004 0.219 to 1.174
Moderate disability 1.285 0.234 0.000 0.827 to 1.744
Age 0.077 0.033 0.021 0.012 to 0.142
Constant 1.029 0.736 0.162 2.471 to 0.413
Sigma
Sigma 1 0.212 0.009 0.195 to 0.230
Sigma 2 0.086 0.019 0.056 to 0.131
Sigma 3 0.061 0.013 0.041 to 0.092
CI, conﬁdence interval; EQ-5D, EuroQol ﬁve-dimensional questionnaire; GOS, Glasgow Outcome Scale; HSPWs, health state preference weights;
SE, standard error.
* Basic GOS coded as indicator variable with GOS 5 (good recovery) as the baseline category. Basic GOS category 1 (death) not modeled because
this will equal 0 by deﬁnition.
† There was a zero probability of membership of class 3 if in persistent vegetative state. This coefﬁcient was therefore constrained to 0.
Covariance matrix is available on request. A Stata “do ﬁle” allowing calculation of mean EQ-5D value with 95% CIs for a given basic GOS and
age category is supplied as an additional ﬁle.
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Fig. 3 – Mean predicted 12-month EQ-5D value for each basic
GOS category at representative ages compared with
observed mean values. Black symbols represent point
estimates from the simple adjusted limited dependent
variable mixture model for predicted mean EQ-5D values
conditional on age (▲, o65 years old, ■, Z65 years old) and
basic GOS category (D, dead; VS, vegetative state; SD, severe
disability; MD, moderate disability; GR, good recovery). Gray
symbols represent corresponding mean observed EQ-5D
values. Error bars report 95% CI for observed and predicted
mean. CI, conﬁdence interval; EQ-5D, EuroQol ﬁve-
dimensional questionnaire; GOS, Glasgow Outcome Scale.
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Summary of Results
The few existing estimates for HSPWs of GOS categories are at
high risk of bias and demonstrate signiﬁcant variation in values.
Adjusted limited dependent variable mixture models are pre-
sented providing predictions for the EQ-5D–based HSPWs of GOS
and extended GOS categories meeting the UK NICE reference
case. In addition to GOS category, age at injury (simple model)
and age, sex, comorbidity, and major extracranial injury (detailed
model) all have small but signiﬁcant independent effects on
mean EQ-5D utility values. Predictions from these models dem-
onstrated excellent goodness of ﬁt to the observed data.Interpretation of Findings
There is a large empirical evidence base demonstrating that the
methods and populations used for health state measurement
and valuation will inﬂuence the magnitude of resulting HSPWs
[12,26–32]. Given that the eligible HSPWs identiﬁed in the system-
atic review comprised a heterogeneous range of study designs, it
is therefore unsurprising that GOS estimates differed signiﬁcantly
between studies. Djikers (2004) used an unorthodox method of
describing health states with subsequent application of generic
preference-based health measures. The lack of descriptive val-
idity inherent in this approach prevents meaningful interpreta-
tion of results. The Rosser Index of Health-Related Quality of Life
has not been widely studied, and it is therefore difﬁcult to
comment on the comparability of utility values reported by Tsauo
(1999) [33]. The ﬁnding that [43], who used the EQ-5D instrument
to measure health status from patients with mild TBI, reported
the lowest HSPWs of the remaining studies is consistent with the
previous observation that indirect valuation tends to result in
lower health ratings compared with direct methods [12]. [40] and[41] directly valued scenarios with the standard gamble approach,
and a number of factors may have been important in producing
the disparate results reported. First, Aoki used very brief GOS
category descriptions, compared with Kosty’s more detailed
narrative vignettes, which may have led respondents to use their
own judgments on the impact of each state with consequently
lower valuations. Second, labeling of health states as posthead
injury by Kosty could have resulted in framing effects, although
this would generally be expected to lower HSPW values [26].
Third, evidence suggests that preferences over health states can
be constructed during interviews, and differences in the format of
the standard gamble exercises may have been important [34].
Finally, little is known about the impact arising from valuation of
health states by health professionals compared with the general
public.
In addition to poor internal validity, it is notable that the studies
identiﬁed in this systematic review are likely to have limited
relevance in future TBI models, underlining the importance of the
developed predictive models. International cost-utility guidelines
generally mandate measurement of health from patients with
standardized and validated generic HRQOL preference measures
[6,12,35], limiting the applicability of Djikers (2004), [40], and [41]
estimates. Additional concerns are the valuation of preferences by
health professionals in Aoki’s study and the nonrepresentative
general population sample providing preferences in Kosty’s study.
Although [43] used the EQ-5D instrument to measure HRQOL from
patients, the sample population comprised a narrow subset of
patients with mild head injury with intracranial CT abnormalities
that may have limited generalizability to other TBI subgroups. Little
information is available on the methodology used to derive the
Rosser health classiﬁcation system’s valuation matrix and the
applicability is consequently uncertain.
Interestingly, the VSTR predictive model suggests that mean
EQ-5D value for unfavorable GOS categories of vegetative state
and severe disability could be lower in younger patients. Such a
pattern could arise if respondents, or their proxies, perceive a
given level of disability to have a lesser impact at older age.
Nevertheless, because this ﬁnding did not reach statistical sig-
niﬁcance, the pattern observed may represent the play of chance.
The opposite relationship between age and utility was apparent
for favorable outcomes of moderate disability and good recovery,
in which utility was signiﬁcantly less in the oldest age groups
compared with the youngest patients. This ﬁnding is unsurpris-
ing because declining HRQOL with age is well established secon-
dary to increasing prevalence of comorbidities and inﬁrmity [36].
Supporting this position, the inﬂuence of age on utility was
reduced in the more detailed predictive model once comorbidity
was added as an explanatory variable. The reduction in utility
associated with major extracranial injury seen in this model is
also intuitive because HRQOL would be expected to decrease in
the presence of pain, depression, and anxiety caused by nonhead
injuries, but which are not fully assessed in the GOS. In common
with previous studies in other disease areas, a reduction in utility
associated with females was apparent [37,38].
A further notable result was that models predicting 12-month
EQ-5D values performed well at 24 months, but underpredicted
EQ-5D at 6 months for those patients with little or no functional
disability. This ﬁnding is likely explained by the evolving nature
of functional recovery during the early postinjury stage, which
may have a bigger impact on EQ-5D within the top categories of
GOS. This position is supported by ﬁndings from the Traumatic
Brain Injury Model Systems National Database which found that
functional status initially improves rapidly before plateauing [39].
The VSTR predictive model is consistent with the NICE
reference case and should therefore be directly relevant to future
UK health technology appraisals [6]. Nevertheless, for these
results to be applicable to other jurisdictions, the statistical
Simple model: Basic GOS, age Detailed model: Basic GOS, age, sex, comorbidity, 
extracranial injury
Within sample predicon : EQ-5D at 12 months post-injury
Out of sample predicon: EQ-5D at 6 months post-injury
Out of sample predicon: EQ-5D at 24 months post-injury
Fig. 4 – Cumulative distribution functions for observed vs. predicted EQ-5D values from predictive models. The x-axis denotes
the EQ-5D and the y-axis displays cumulative percentage of cases. EQ-5D, EuroQol ﬁve-dimensional questionnaire; GOS,
Glasgow Outcome Scale.
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be the same in the economic evaluation’s modeled population asthat in the VSTR estimation sample. Differences could arise
because of the type of TBI, variation in population attributes, or
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demographic characteristics, the results are likely to be applica-
ble to North American and Western European populations in the
ﬁrst few years following TBI, but generalizability to other coun-
tries and time points is less certain.
Study Strengths and Limitations
The systematic review beneﬁts from concordance with methodo-
logical guidelines, sensitive search terms, and an extensive
search strategy covering all potentially useful information sour-
ces. Identifying HSPW data, however, is challenging because of
the lack of validated methodological search ﬁlters, nonspeciﬁc
thesauri terms in bibliographic databases, and lack of clear
reporting of HSPW studies in titles and abstracts [5]. It is therefore
possible that not all GOS HSPWs were identiﬁed. There are no
accepted critical appraisal tools for judging the risk of bias or
evaluating the use of HSPWs within decision analysis models,
and although we have based our assessment on published
recommendations and expert guidelines our methods have not
been fully validated.
The utility mapping study also has a number of strengths.
Because data submission to VSTR is mandatory, incomplete
database enrollment is unlikely and the study’s sampling frame
can be considered to be comprehensively population-based.
Levels of missing covariate data were comparatively low because
of careful matching of interhospital transfers and thorough data
collection processes. Furthermore, the mixture modeling
approach is speciﬁcally designed to produce appropriate esti-
mates of EQ-5D from clinical and other predictors, and has been
shown to be superior to other statistical techniques.
Conversely, a number of limitations arising from patient
attrition, sparse data, measurement error, and uncertainties
surrounding EQ-5D index values could potentially undermine
the internal validity of results. Although the relatively high loss
to follow-up of 20% raises the possibility of selection bias,
included cases appeared to be representative of the overall study
population (see the Web Appendix in Supplemental Materials).
Very few patients (six cases) with vegetative state were available
in the study sample, leading to imprecise point estimates
and very large standard errors for relevant coefﬁcients in the
primary model examining basic GOS and age. Nevertheless,
repeating the analyses after combining vegetative state and
severe disability categories, or excluding vegetative state patients
from the estimation sample, did not change predictions for other
health states, suggesting that sparse data for this outcome group
did not adversely affect model performance (data not shown).
Systematic misclassiﬁcation of GOS categories and other
covariates, or differential measurement error in EQ-5D assess-
ments, could lead to incorrect HSPW estimates. Random
errors arising from interobserver variability or coding mistakes
are, however, more plausible, leading to unbiased but less precise
predictions. An additional limitation is that the predictive
models have assumed that EQ-5D index values are actual
distinct values, when in reality they are themselves uncertain
estimates derived from a regression model [23]. The 95%
CIs surrounding the reported HSPWs are consequently slightly
underestimated.Conclusions
This is the ﬁrst known study to systematically identify, character-
ize, and appraise available HSPWs for GOS categories following
TBI. The small number of existing estimates are challenged by
potential biases and restricted generalizability, limiting their use
in TBI economic evaluations. We have consequently developed arobust model giving valid and applicable utility estimates for
GOS health states meeting the NICE reference case, providing a
valuable resource for parameterization of future economic models.
A program ﬁle is supplied, allowing simple calculation of mean
utility values and 95% CIs conditional on important patient
characteristics.Acknowledgments
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